1-year clinical outcomes of diabetic patients treated with everolimus-eluting bioresorbable vascular scaffolds: a pooled analysis of the ABSORB and the SPIRIT trials.
Identifieur interne : 003877 ( PubMed/Checkpoint ); précédent : 003876; suivant : 0038781-year clinical outcomes of diabetic patients treated with everolimus-eluting bioresorbable vascular scaffolds: a pooled analysis of the ABSORB and the SPIRIT trials.
Auteurs : Takashi Muramatsu [Japon] ; Yoshinobu Onuma [Pays-Bas] ; Robert-Jan Van Geuns [Pays-Bas] ; Bernard Chevalier [France] ; Tejas M. Patel [Inde] ; Ashok Seth [Inde] ; Roberto Diletti [Pays-Bas] ; Hector M. García-García [Pays-Bas] ; Cécile C. Dorange [Belgique] ; Susan Veldhof [Belgique] ; Wai-Fung Cheong [États-Unis] ; Yukio Ozaki [Japon] ; Robert Whitbourn [Australie] ; Antonio Bartorelli [Italie] ; Gregg W. Stone [États-Unis] ; Alexandre Abizaid [Brésil] ; Patrick W. Serruys [Pays-Bas]Source :
- JACC. Cardiovascular interventions [ 1876-7605 ] ; 2014.
Descripteurs français
- KwdFr :
- Adulte d'âge moyen, Agents cardiovasculaires (administration et posologie), Angiopathies diabétiques (), Angiopathies diabétiques (diagnostic), Angiopathies diabétiques (mortalité), Conception de prothèse, Essais cliniques comme sujet, Estimation de Kaplan-Meier, Facteurs de risque, Facteurs temps, Femelle, Humains, Implant résorbable, Incidence, Infarctus du myocarde (mortalité), Infarctus du myocarde (étiologie), Loi du khi-deux, Mâle, Résultat thérapeutique, Score de propension, Sirolimus (administration et posologie), Sirolimus (analogues et dérivés), Sténose coronarienne (), Sténose coronarienne (diagnostic), Sténose coronarienne (mortalité), Sujet âgé, Thrombose coronarienne (mortalité), Thrombose coronarienne (étiologie), Études de suivi, Évérolimus.
- MESH :
- administration et posologie : Agents cardiovasculaires, Sirolimus.
- analogues et dérivés : Sirolimus.
- diagnostic : Angiopathies diabétiques, Sténose coronarienne.
- mortalité : Angiopathies diabétiques, Infarctus du myocarde, Sténose coronarienne, Thrombose coronarienne.
- étiologie : Infarctus du myocarde, Thrombose coronarienne.
- Adulte d'âge moyen, Angiopathies diabétiques, Conception de prothèse, Essais cliniques comme sujet, Estimation de Kaplan-Meier, Facteurs de risque, Facteurs temps, Femelle, Humains, Implant résorbable, Incidence, Loi du khi-deux, Mâle, Résultat thérapeutique, Score de propension, Sténose coronarienne, Sujet âgé, Études de suivi, Évérolimus.
English descriptors
- KwdEn :
- Absorbable Implants, Aged, Cardiovascular Agents (administration & dosage), Chi-Square Distribution, Clinical Trials as Topic, Coronary Stenosis (diagnosis), Coronary Stenosis (mortality), Coronary Stenosis (therapy), Coronary Thrombosis (etiology), Coronary Thrombosis (mortality), Diabetic Angiopathies (diagnosis), Diabetic Angiopathies (mortality), Diabetic Angiopathies (therapy), Everolimus, Female, Follow-Up Studies, Humans, Incidence, Kaplan-Meier Estimate, Male, Middle Aged, Myocardial Infarction (etiology), Myocardial Infarction (mortality), Propensity Score, Prosthesis Design, Risk Factors, Sirolimus (administration & dosage), Sirolimus (analogs & derivatives), Time Factors, Treatment Outcome.
- MESH :
- chemical , administration & dosage : Cardiovascular Agents, Sirolimus.
- chemical , analogs & derivatives : Sirolimus.
- diagnosis : Coronary Stenosis, Diabetic Angiopathies.
- etiology : Coronary Thrombosis, Myocardial Infarction.
- mortality : Coronary Stenosis, Coronary Thrombosis, Diabetic Angiopathies, Myocardial Infarction.
- therapy : Coronary Stenosis, Diabetic Angiopathies.
- Absorbable Implants, Aged, Chi-Square Distribution, Clinical Trials as Topic, Everolimus, Female, Follow-Up Studies, Humans, Incidence, Kaplan-Meier Estimate, Male, Middle Aged, Propensity Score, Prosthesis Design, Risk Factors, Time Factors, Treatment Outcome.
Abstract
The aim of this study was to evaluate 1-year clinical outcomes of diabetic patients treated with the Absorb bioresorbable vascular scaffold (BVS).
DOI: 10.1016/j.jcin.2014.01.155
PubMed: 24746650
Affiliations:
- Australie, Belgique, Brésil, France, Inde, Italie, Japon, Pays-Bas, États-Unis
- Californie, Hollande-Méridionale, Lombardie, État de New York, État de São Paulo
- Milan, Rotterdam, São Paulo
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:24746650Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">1-year clinical outcomes of diabetic patients treated with everolimus-eluting bioresorbable vascular scaffolds: a pooled analysis of the ABSORB and the SPIRIT trials.</title><author><name sortKey="Muramatsu, Takashi" sort="Muramatsu, Takashi" uniqKey="Muramatsu T" first="Takashi" last="Muramatsu">Takashi Muramatsu</name><affiliation wicri:level="1"><nlm:affiliation>Thoraxcenter, Erasmus Medical Center, Rotterdam, the Netherlands; Department of Cardiology, Fujita Health University Hospital, Toyoake, Japan.</nlm:affiliation><country xml:lang="fr">Japon</country><wicri:regionArea>Thoraxcenter, Erasmus Medical Center, Rotterdam, the Netherlands; Department of Cardiology, Fujita Health University Hospital, Toyoake</wicri:regionArea><wicri:noRegion>Toyoake</wicri:noRegion></affiliation></author><author><name sortKey="Onuma, Yoshinobu" sort="Onuma, Yoshinobu" uniqKey="Onuma Y" first="Yoshinobu" last="Onuma">Yoshinobu Onuma</name><affiliation wicri:level="3"><nlm:affiliation>Thoraxcenter, Erasmus Medical Center, Rotterdam, the Netherlands.</nlm:affiliation><country xml:lang="fr" wicri:curation="lc">Pays-Bas</country><wicri:regionArea>Thoraxcenter, Erasmus Medical Center, Rotterdam</wicri:regionArea><placeName><settlement type="city">Rotterdam</settlement><region nuts="2" type="province">Hollande-Méridionale</region></placeName></affiliation></author><author><name sortKey="Van Geuns, Robert Jan" sort="Van Geuns, Robert Jan" uniqKey="Van Geuns R" first="Robert-Jan" last="Van Geuns">Robert-Jan Van Geuns</name><affiliation wicri:level="3"><nlm:affiliation>Thoraxcenter, Erasmus Medical Center, Rotterdam, the Netherlands.</nlm:affiliation><country xml:lang="fr" wicri:curation="lc">Pays-Bas</country><wicri:regionArea>Thoraxcenter, Erasmus Medical Center, Rotterdam</wicri:regionArea><placeName><settlement type="city">Rotterdam</settlement><region nuts="2" type="province">Hollande-Méridionale</region></placeName></affiliation></author><author><name sortKey="Chevalier, Bernard" sort="Chevalier, Bernard" uniqKey="Chevalier B" first="Bernard" last="Chevalier">Bernard Chevalier</name><affiliation wicri:level="1"><nlm:affiliation>Institut Cardiovasculaire Paris Sud, Massy, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Institut Cardiovasculaire Paris Sud, Massy</wicri:regionArea><wicri:noRegion>Massy</wicri:noRegion><wicri:noRegion>Massy</wicri:noRegion></affiliation></author><author><name sortKey="Patel, Tejas M" sort="Patel, Tejas M" uniqKey="Patel T" first="Tejas M" last="Patel">Tejas M. Patel</name><affiliation wicri:level="1"><nlm:affiliation>Krishna Heart Institute, Ahmedabad, India.</nlm:affiliation><country xml:lang="fr">Inde</country><wicri:regionArea>Krishna Heart Institute, Ahmedabad</wicri:regionArea><wicri:noRegion>Ahmedabad</wicri:noRegion></affiliation></author><author><name sortKey="Seth, Ashok" sort="Seth, Ashok" uniqKey="Seth A" first="Ashok" last="Seth">Ashok Seth</name><affiliation wicri:level="1"><nlm:affiliation>Fortis Escorts Heart Institute, New Delhi, India.</nlm:affiliation><country xml:lang="fr">Inde</country><wicri:regionArea>Fortis Escorts Heart Institute, New Delhi</wicri:regionArea><wicri:noRegion>New Delhi</wicri:noRegion></affiliation></author><author><name sortKey="Diletti, Roberto" sort="Diletti, Roberto" uniqKey="Diletti R" first="Roberto" last="Diletti">Roberto Diletti</name><affiliation wicri:level="3"><nlm:affiliation>Thoraxcenter, Erasmus Medical Center, Rotterdam, the Netherlands.</nlm:affiliation><country xml:lang="fr" wicri:curation="lc">Pays-Bas</country><wicri:regionArea>Thoraxcenter, Erasmus Medical Center, Rotterdam</wicri:regionArea><placeName><settlement type="city">Rotterdam</settlement><region nuts="2" type="province">Hollande-Méridionale</region></placeName></affiliation></author><author><name sortKey="Garcia Garcia, Hector M" sort="Garcia Garcia, Hector M" uniqKey="Garcia Garcia H" first="Hector M" last="García-García">Hector M. García-García</name><affiliation wicri:level="3"><nlm:affiliation>Thoraxcenter, Erasmus Medical Center, Rotterdam, the Netherlands.</nlm:affiliation><country xml:lang="fr" wicri:curation="lc">Pays-Bas</country><wicri:regionArea>Thoraxcenter, Erasmus Medical Center, Rotterdam</wicri:regionArea><placeName><settlement type="city">Rotterdam</settlement><region nuts="2" type="province">Hollande-Méridionale</region></placeName></affiliation></author><author><name sortKey="Dorange, Cecile C" sort="Dorange, Cecile C" uniqKey="Dorange C" first="Cécile C" last="Dorange">Cécile C. Dorange</name><affiliation wicri:level="1"><nlm:affiliation>Abbott Vascular, Diegem, Belgium.</nlm:affiliation><country xml:lang="fr">Belgique</country><wicri:regionArea>Abbott Vascular, Diegem</wicri:regionArea><wicri:noRegion>Diegem</wicri:noRegion></affiliation></author><author><name sortKey="Veldhof, Susan" sort="Veldhof, Susan" uniqKey="Veldhof S" first="Susan" last="Veldhof">Susan Veldhof</name><affiliation wicri:level="1"><nlm:affiliation>Abbott Vascular, Diegem, Belgium.</nlm:affiliation><country xml:lang="fr">Belgique</country><wicri:regionArea>Abbott Vascular, Diegem</wicri:regionArea><wicri:noRegion>Diegem</wicri:noRegion></affiliation></author><author><name sortKey="Cheong, Wai Fung" sort="Cheong, Wai Fung" uniqKey="Cheong W" first="Wai-Fung" last="Cheong">Wai-Fung Cheong</name><affiliation wicri:level="2"><nlm:affiliation>Abbott Vascular, Santa Clara, California.</nlm:affiliation><country>États-Unis</country><placeName><region type="state">Californie</region></placeName><wicri:cityArea>Abbott Vascular, Santa Clara</wicri:cityArea></affiliation></author><author><name sortKey="Ozaki, Yukio" sort="Ozaki, Yukio" uniqKey="Ozaki Y" first="Yukio" last="Ozaki">Yukio Ozaki</name><affiliation wicri:level="1"><nlm:affiliation>Department of Cardiology, Fujita Health University Hospital, Toyoake, Japan.</nlm:affiliation><country xml:lang="fr">Japon</country><wicri:regionArea>Department of Cardiology, Fujita Health University Hospital, Toyoake</wicri:regionArea><wicri:noRegion>Toyoake</wicri:noRegion></affiliation></author><author><name sortKey="Whitbourn, Robert" sort="Whitbourn, Robert" uniqKey="Whitbourn R" first="Robert" last="Whitbourn">Robert Whitbourn</name><affiliation wicri:level="1"><nlm:affiliation>Cardiovascular Research Center, St. Vincent's Hospital, Melbourne, Victoria, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Cardiovascular Research Center, St. Vincent's Hospital, Melbourne, Victoria</wicri:regionArea><wicri:noRegion>Victoria</wicri:noRegion></affiliation></author><author><name sortKey="Bartorelli, Antonio" sort="Bartorelli, Antonio" uniqKey="Bartorelli A" first="Antonio" last="Bartorelli">Antonio Bartorelli</name><affiliation wicri:level="3"><nlm:affiliation>Centro Cardiologico Monzino, IRCCS, University of Milan, Milan, Italy.</nlm:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>Centro Cardiologico Monzino, IRCCS, University of Milan, Milan</wicri:regionArea><placeName><settlement type="city">Milan</settlement><region nuts="2">Lombardie</region></placeName></affiliation></author><author><name sortKey="Stone, Gregg W" sort="Stone, Gregg W" uniqKey="Stone G" first="Gregg W" last="Stone">Gregg W. Stone</name><affiliation wicri:level="2"><nlm:affiliation>Columbia University Medical Center/New York-Presbyterian Hospital and Cardiovascular Research Foundation, New York, New York.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">État de New York</region></placeName><wicri:cityArea>Columbia University Medical Center/New York-Presbyterian Hospital and Cardiovascular Research Foundation, New York</wicri:cityArea></affiliation></author><author><name sortKey="Abizaid, Alexandre" sort="Abizaid, Alexandre" uniqKey="Abizaid A" first="Alexandre" last="Abizaid">Alexandre Abizaid</name><affiliation wicri:level="3"><nlm:affiliation>Instituto Dante Pazzanese de Cardiologia, São Paulo, Brazil.</nlm:affiliation><country xml:lang="fr">Brésil</country><wicri:regionArea>Instituto Dante Pazzanese de Cardiologia, São Paulo</wicri:regionArea><placeName><settlement type="city">São Paulo</settlement><region type="state">État de São Paulo</region></placeName></affiliation></author><author><name sortKey="Serruys, Patrick W" sort="Serruys, Patrick W" uniqKey="Serruys P" first="Patrick W" last="Serruys">Patrick W. Serruys</name><affiliation wicri:level="3"><nlm:affiliation>Thoraxcenter, Erasmus Medical Center, Rotterdam, the Netherlands. Electronic address: p.w.j.c.serruys@erasmusmc.nl.</nlm:affiliation><country xml:lang="fr" wicri:curation="lc">Pays-Bas</country><wicri:regionArea>Thoraxcenter, Erasmus Medical Center, Rotterdam</wicri:regionArea><placeName><settlement type="city">Rotterdam</settlement><region nuts="2" type="province">Hollande-Méridionale</region></placeName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2014">2014</date><idno type="RBID">pubmed:24746650</idno><idno type="pmid">24746650</idno><idno type="doi">10.1016/j.jcin.2014.01.155</idno><idno type="wicri:Area/PubMed/Corpus">003776</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">003776</idno><idno type="wicri:Area/PubMed/Curation">003662</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">003662</idno><idno type="wicri:Area/PubMed/Checkpoint">003662</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">003662</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">1-year clinical outcomes of diabetic patients treated with everolimus-eluting bioresorbable vascular scaffolds: a pooled analysis of the ABSORB and the SPIRIT trials.</title><author><name sortKey="Muramatsu, Takashi" sort="Muramatsu, Takashi" uniqKey="Muramatsu T" first="Takashi" last="Muramatsu">Takashi Muramatsu</name><affiliation wicri:level="1"><nlm:affiliation>Thoraxcenter, Erasmus Medical Center, Rotterdam, the Netherlands; Department of Cardiology, Fujita Health University Hospital, Toyoake, Japan.</nlm:affiliation><country xml:lang="fr">Japon</country><wicri:regionArea>Thoraxcenter, Erasmus Medical Center, Rotterdam, the Netherlands; Department of Cardiology, Fujita Health University Hospital, Toyoake</wicri:regionArea><wicri:noRegion>Toyoake</wicri:noRegion></affiliation></author><author><name sortKey="Onuma, Yoshinobu" sort="Onuma, Yoshinobu" uniqKey="Onuma Y" first="Yoshinobu" last="Onuma">Yoshinobu Onuma</name><affiliation wicri:level="3"><nlm:affiliation>Thoraxcenter, Erasmus Medical Center, Rotterdam, the Netherlands.</nlm:affiliation><country xml:lang="fr" wicri:curation="lc">Pays-Bas</country><wicri:regionArea>Thoraxcenter, Erasmus Medical Center, Rotterdam</wicri:regionArea><placeName><settlement type="city">Rotterdam</settlement><region nuts="2" type="province">Hollande-Méridionale</region></placeName></affiliation></author><author><name sortKey="Van Geuns, Robert Jan" sort="Van Geuns, Robert Jan" uniqKey="Van Geuns R" first="Robert-Jan" last="Van Geuns">Robert-Jan Van Geuns</name><affiliation wicri:level="3"><nlm:affiliation>Thoraxcenter, Erasmus Medical Center, Rotterdam, the Netherlands.</nlm:affiliation><country xml:lang="fr" wicri:curation="lc">Pays-Bas</country><wicri:regionArea>Thoraxcenter, Erasmus Medical Center, Rotterdam</wicri:regionArea><placeName><settlement type="city">Rotterdam</settlement><region nuts="2" type="province">Hollande-Méridionale</region></placeName></affiliation></author><author><name sortKey="Chevalier, Bernard" sort="Chevalier, Bernard" uniqKey="Chevalier B" first="Bernard" last="Chevalier">Bernard Chevalier</name><affiliation wicri:level="1"><nlm:affiliation>Institut Cardiovasculaire Paris Sud, Massy, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Institut Cardiovasculaire Paris Sud, Massy</wicri:regionArea><wicri:noRegion>Massy</wicri:noRegion><wicri:noRegion>Massy</wicri:noRegion></affiliation></author><author><name sortKey="Patel, Tejas M" sort="Patel, Tejas M" uniqKey="Patel T" first="Tejas M" last="Patel">Tejas M. Patel</name><affiliation wicri:level="1"><nlm:affiliation>Krishna Heart Institute, Ahmedabad, India.</nlm:affiliation><country xml:lang="fr">Inde</country><wicri:regionArea>Krishna Heart Institute, Ahmedabad</wicri:regionArea><wicri:noRegion>Ahmedabad</wicri:noRegion></affiliation></author><author><name sortKey="Seth, Ashok" sort="Seth, Ashok" uniqKey="Seth A" first="Ashok" last="Seth">Ashok Seth</name><affiliation wicri:level="1"><nlm:affiliation>Fortis Escorts Heart Institute, New Delhi, India.</nlm:affiliation><country xml:lang="fr">Inde</country><wicri:regionArea>Fortis Escorts Heart Institute, New Delhi</wicri:regionArea><wicri:noRegion>New Delhi</wicri:noRegion></affiliation></author><author><name sortKey="Diletti, Roberto" sort="Diletti, Roberto" uniqKey="Diletti R" first="Roberto" last="Diletti">Roberto Diletti</name><affiliation wicri:level="3"><nlm:affiliation>Thoraxcenter, Erasmus Medical Center, Rotterdam, the Netherlands.</nlm:affiliation><country xml:lang="fr" wicri:curation="lc">Pays-Bas</country><wicri:regionArea>Thoraxcenter, Erasmus Medical Center, Rotterdam</wicri:regionArea><placeName><settlement type="city">Rotterdam</settlement><region nuts="2" type="province">Hollande-Méridionale</region></placeName></affiliation></author><author><name sortKey="Garcia Garcia, Hector M" sort="Garcia Garcia, Hector M" uniqKey="Garcia Garcia H" first="Hector M" last="García-García">Hector M. García-García</name><affiliation wicri:level="3"><nlm:affiliation>Thoraxcenter, Erasmus Medical Center, Rotterdam, the Netherlands.</nlm:affiliation><country xml:lang="fr" wicri:curation="lc">Pays-Bas</country><wicri:regionArea>Thoraxcenter, Erasmus Medical Center, Rotterdam</wicri:regionArea><placeName><settlement type="city">Rotterdam</settlement><region nuts="2" type="province">Hollande-Méridionale</region></placeName></affiliation></author><author><name sortKey="Dorange, Cecile C" sort="Dorange, Cecile C" uniqKey="Dorange C" first="Cécile C" last="Dorange">Cécile C. Dorange</name><affiliation wicri:level="1"><nlm:affiliation>Abbott Vascular, Diegem, Belgium.</nlm:affiliation><country xml:lang="fr">Belgique</country><wicri:regionArea>Abbott Vascular, Diegem</wicri:regionArea><wicri:noRegion>Diegem</wicri:noRegion></affiliation></author><author><name sortKey="Veldhof, Susan" sort="Veldhof, Susan" uniqKey="Veldhof S" first="Susan" last="Veldhof">Susan Veldhof</name><affiliation wicri:level="1"><nlm:affiliation>Abbott Vascular, Diegem, Belgium.</nlm:affiliation><country xml:lang="fr">Belgique</country><wicri:regionArea>Abbott Vascular, Diegem</wicri:regionArea><wicri:noRegion>Diegem</wicri:noRegion></affiliation></author><author><name sortKey="Cheong, Wai Fung" sort="Cheong, Wai Fung" uniqKey="Cheong W" first="Wai-Fung" last="Cheong">Wai-Fung Cheong</name><affiliation wicri:level="2"><nlm:affiliation>Abbott Vascular, Santa Clara, California.</nlm:affiliation><country>États-Unis</country><placeName><region type="state">Californie</region></placeName><wicri:cityArea>Abbott Vascular, Santa Clara</wicri:cityArea></affiliation></author><author><name sortKey="Ozaki, Yukio" sort="Ozaki, Yukio" uniqKey="Ozaki Y" first="Yukio" last="Ozaki">Yukio Ozaki</name><affiliation wicri:level="1"><nlm:affiliation>Department of Cardiology, Fujita Health University Hospital, Toyoake, Japan.</nlm:affiliation><country xml:lang="fr">Japon</country><wicri:regionArea>Department of Cardiology, Fujita Health University Hospital, Toyoake</wicri:regionArea><wicri:noRegion>Toyoake</wicri:noRegion></affiliation></author><author><name sortKey="Whitbourn, Robert" sort="Whitbourn, Robert" uniqKey="Whitbourn R" first="Robert" last="Whitbourn">Robert Whitbourn</name><affiliation wicri:level="1"><nlm:affiliation>Cardiovascular Research Center, St. Vincent's Hospital, Melbourne, Victoria, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Cardiovascular Research Center, St. Vincent's Hospital, Melbourne, Victoria</wicri:regionArea><wicri:noRegion>Victoria</wicri:noRegion></affiliation></author><author><name sortKey="Bartorelli, Antonio" sort="Bartorelli, Antonio" uniqKey="Bartorelli A" first="Antonio" last="Bartorelli">Antonio Bartorelli</name><affiliation wicri:level="3"><nlm:affiliation>Centro Cardiologico Monzino, IRCCS, University of Milan, Milan, Italy.</nlm:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>Centro Cardiologico Monzino, IRCCS, University of Milan, Milan</wicri:regionArea><placeName><settlement type="city">Milan</settlement><region nuts="2">Lombardie</region></placeName></affiliation></author><author><name sortKey="Stone, Gregg W" sort="Stone, Gregg W" uniqKey="Stone G" first="Gregg W" last="Stone">Gregg W. Stone</name><affiliation wicri:level="2"><nlm:affiliation>Columbia University Medical Center/New York-Presbyterian Hospital and Cardiovascular Research Foundation, New York, New York.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">État de New York</region></placeName><wicri:cityArea>Columbia University Medical Center/New York-Presbyterian Hospital and Cardiovascular Research Foundation, New York</wicri:cityArea></affiliation></author><author><name sortKey="Abizaid, Alexandre" sort="Abizaid, Alexandre" uniqKey="Abizaid A" first="Alexandre" last="Abizaid">Alexandre Abizaid</name><affiliation wicri:level="3"><nlm:affiliation>Instituto Dante Pazzanese de Cardiologia, São Paulo, Brazil.</nlm:affiliation><country xml:lang="fr">Brésil</country><wicri:regionArea>Instituto Dante Pazzanese de Cardiologia, São Paulo</wicri:regionArea><placeName><settlement type="city">São Paulo</settlement><region type="state">État de São Paulo</region></placeName></affiliation></author><author><name sortKey="Serruys, Patrick W" sort="Serruys, Patrick W" uniqKey="Serruys P" first="Patrick W" last="Serruys">Patrick W. Serruys</name><affiliation wicri:level="3"><nlm:affiliation>Thoraxcenter, Erasmus Medical Center, Rotterdam, the Netherlands. Electronic address: p.w.j.c.serruys@erasmusmc.nl.</nlm:affiliation><country xml:lang="fr" wicri:curation="lc">Pays-Bas</country><wicri:regionArea>Thoraxcenter, Erasmus Medical Center, Rotterdam</wicri:regionArea><placeName><settlement type="city">Rotterdam</settlement><region nuts="2" type="province">Hollande-Méridionale</region></placeName></affiliation></author></analytic><series><title level="j">JACC. Cardiovascular interventions</title><idno type="eISSN">1876-7605</idno><imprint><date when="2014" type="published">2014</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Absorbable Implants</term><term>Aged</term><term>Cardiovascular Agents (administration & dosage)</term><term>Chi-Square Distribution</term><term>Clinical Trials as Topic</term><term>Coronary Stenosis (diagnosis)</term><term>Coronary Stenosis (mortality)</term><term>Coronary Stenosis (therapy)</term><term>Coronary Thrombosis (etiology)</term><term>Coronary Thrombosis (mortality)</term><term>Diabetic Angiopathies (diagnosis)</term><term>Diabetic Angiopathies (mortality)</term><term>Diabetic Angiopathies (therapy)</term><term>Everolimus</term><term>Female</term><term>Follow-Up Studies</term><term>Humans</term><term>Incidence</term><term>Kaplan-Meier Estimate</term><term>Male</term><term>Middle Aged</term><term>Myocardial Infarction (etiology)</term><term>Myocardial Infarction (mortality)</term><term>Propensity Score</term><term>Prosthesis Design</term><term>Risk Factors</term><term>Sirolimus (administration & dosage)</term><term>Sirolimus (analogs & derivatives)</term><term>Time Factors</term><term>Treatment Outcome</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte d'âge moyen</term><term>Agents cardiovasculaires (administration et posologie)</term><term>Angiopathies diabétiques ()</term><term>Angiopathies diabétiques (diagnostic)</term><term>Angiopathies diabétiques (mortalité)</term><term>Conception de prothèse</term><term>Essais cliniques comme sujet</term><term>Estimation de Kaplan-Meier</term><term>Facteurs de risque</term><term>Facteurs temps</term><term>Femelle</term><term>Humains</term><term>Implant résorbable</term><term>Incidence</term><term>Infarctus du myocarde (mortalité)</term><term>Infarctus du myocarde (étiologie)</term><term>Loi du khi-deux</term><term>Mâle</term><term>Résultat thérapeutique</term><term>Score de propension</term><term>Sirolimus (administration et posologie)</term><term>Sirolimus (analogues et dérivés)</term><term>Sténose coronarienne ()</term><term>Sténose coronarienne (diagnostic)</term><term>Sténose coronarienne (mortalité)</term><term>Sujet âgé</term><term>Thrombose coronarienne (mortalité)</term><term>Thrombose coronarienne (étiologie)</term><term>Études de suivi</term><term>Évérolimus</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Cardiovascular Agents</term><term>Sirolimus</term></keywords><keywords scheme="MESH" type="chemical" qualifier="analogs & derivatives" xml:lang="en"><term>Sirolimus</term></keywords><keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Agents cardiovasculaires</term><term>Sirolimus</term></keywords><keywords scheme="MESH" qualifier="analogues et dérivés" xml:lang="fr"><term>Sirolimus</term></keywords><keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Coronary Stenosis</term><term>Diabetic Angiopathies</term></keywords><keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr"><term>Angiopathies diabétiques</term><term>Sténose coronarienne</term></keywords><keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Coronary Thrombosis</term><term>Myocardial Infarction</term></keywords><keywords scheme="MESH" qualifier="mortality" xml:lang="en"><term>Coronary Stenosis</term><term>Coronary Thrombosis</term><term>Diabetic Angiopathies</term><term>Myocardial Infarction</term></keywords><keywords scheme="MESH" qualifier="mortalité" xml:lang="fr"><term>Angiopathies diabétiques</term><term>Infarctus du myocarde</term><term>Sténose coronarienne</term><term>Thrombose coronarienne</term></keywords><keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Coronary Stenosis</term><term>Diabetic Angiopathies</term></keywords><keywords scheme="MESH" qualifier="étiologie" xml:lang="fr"><term>Infarctus du myocarde</term><term>Thrombose coronarienne</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Absorbable Implants</term><term>Aged</term><term>Chi-Square Distribution</term><term>Clinical Trials as Topic</term><term>Everolimus</term><term>Female</term><term>Follow-Up Studies</term><term>Humans</term><term>Incidence</term><term>Kaplan-Meier Estimate</term><term>Male</term><term>Middle Aged</term><term>Propensity Score</term><term>Prosthesis Design</term><term>Risk Factors</term><term>Time Factors</term><term>Treatment Outcome</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte d'âge moyen</term><term>Angiopathies diabétiques</term><term>Conception de prothèse</term><term>Essais cliniques comme sujet</term><term>Estimation de Kaplan-Meier</term><term>Facteurs de risque</term><term>Facteurs temps</term><term>Femelle</term><term>Humains</term><term>Implant résorbable</term><term>Incidence</term><term>Loi du khi-deux</term><term>Mâle</term><term>Résultat thérapeutique</term><term>Score de propension</term><term>Sténose coronarienne</term><term>Sujet âgé</term><term>Études de suivi</term><term>Évérolimus</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The aim of this study was to evaluate 1-year clinical outcomes of diabetic patients treated with the Absorb bioresorbable vascular scaffold (BVS).</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">24746650</PMID><DateCreated><Year>2014</Year><Month>05</Month><Day>23</Day></DateCreated><DateCompleted><Year>2015</Year><Month>01</Month><Day>30</Day></DateCompleted><DateRevised><Year>2015</Year><Month>11</Month><Day>19</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1876-7605</ISSN><JournalIssue CitedMedium="Internet"><Volume>7</Volume><Issue>5</Issue><PubDate><Year>2014</Year><Month>May</Month></PubDate></JournalIssue><Title>JACC. Cardiovascular interventions</Title><ISOAbbreviation>JACC Cardiovasc Interv</ISOAbbreviation></Journal><ArticleTitle>1-year clinical outcomes of diabetic patients treated with everolimus-eluting bioresorbable vascular scaffolds: a pooled analysis of the ABSORB and the SPIRIT trials.</ArticleTitle><Pagination><MedlinePgn>482-93</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jcin.2014.01.155</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1936-8798(14)00507-X</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">The aim of this study was to evaluate 1-year clinical outcomes of diabetic patients treated with the Absorb bioresorbable vascular scaffold (BVS).</AbstractText><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Clinical outcomes of diabetic patients after BVS implantation have been unreported.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This study included 101 patients in the ABSORB Cohort B trial and the first consecutive 450 patients with 1 year of follow-up in the ABSORB EXTEND trial. A total of 136 diabetic patients were compared with 415 nondiabetic patients. In addition, 882 diabetic patients treated with everolimus-eluting metal stents (EES) in pooled data from the SPIRIT trials (SPIRIT FIRST [Clinical Trial of the Abbott Vascular XIENCE V Everolimus Eluting Coronary Stent System], SPIRIT II [A Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System], SPIRIT III [Clinical Trial of the XIENCE V Everolimus Eluting Coronary Stent System (EECSS)], SPIRIT IV Clinical Trial [Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System]) were used for the comparison by applying propensity score matching. The primary endpoint was a device-oriented composite endpoint (DoCE), including cardiac death, target vessel myocardial infarction, and target lesion revascularization at 1-year follow-up.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The cumulative incidence of DoCE did not differ between diabetic and nondiabetic patients treated with the BVS (3.7% vs. 5.1%, p = 0.64). Diabetic patients treated with the BVS had a similar incidence of the DoCE compared with diabetic patients treated with EES in the matched study group (3.9% for the BVS vs. 6.4% for EES, p = 0.38). There were no differences in the incidence of definite or probable scaffold/stent thrombosis (0.7% for both diabetic and nondiabetic patients with the BVS; 1.0% for diabetic patients with the BVS vs. 1.7% for diabetic patients with EES in the matched study group).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">In the present analyses, diabetic patients treated with the BVS showed similar rates of DoCEs compared with nondiabetic patients treated with the BVS and diabetic patients treated with EES at 1-year follow-up. (ABSORB Clinical Investigation, Cohort B; NCT00856856; ABSORB EXTEND Clinical Investigation; NCT01023789; Clinical Trial of the Abbott Vascular XIENCE V Everolimus Eluting Coronary Stent System [SPIRIT FIRST]; NCT00180453; A Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System [SPIRIT II]; NCT00180310; Clinical Trial of the XIENCE V Everolimus Eluting Coronary Stent System [EECSS] [SPIRIT III]; NCT00180479; Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System [SPIRIT IV Clinical Trial]; NCT00307047).</AbstractText><CopyrightInformation>Copyright © 2014 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Muramatsu</LastName><ForeName>Takashi</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Thoraxcenter, Erasmus Medical Center, Rotterdam, the Netherlands; Department of Cardiology, Fujita Health University Hospital, Toyoake, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Onuma</LastName><ForeName>Yoshinobu</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Thoraxcenter, Erasmus Medical Center, Rotterdam, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van Geuns</LastName><ForeName>Robert-Jan</ForeName><Initials>RJ</Initials><AffiliationInfo><Affiliation>Thoraxcenter, Erasmus Medical Center, Rotterdam, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chevalier</LastName><ForeName>Bernard</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Institut Cardiovasculaire Paris Sud, Massy, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Patel</LastName><ForeName>Tejas M</ForeName><Initials>TM</Initials><AffiliationInfo><Affiliation>Krishna Heart Institute, Ahmedabad, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Seth</LastName><ForeName>Ashok</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Fortis Escorts Heart Institute, New Delhi, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Diletti</LastName><ForeName>Roberto</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Thoraxcenter, Erasmus Medical Center, Rotterdam, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>García-García</LastName><ForeName>Hector M</ForeName><Initials>HM</Initials><AffiliationInfo><Affiliation>Thoraxcenter, Erasmus Medical Center, Rotterdam, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dorange</LastName><ForeName>Cécile C</ForeName><Initials>CC</Initials><AffiliationInfo><Affiliation>Abbott Vascular, Diegem, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Veldhof</LastName><ForeName>Susan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Abbott Vascular, Diegem, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cheong</LastName><ForeName>Wai-Fung</ForeName><Initials>WF</Initials><AffiliationInfo><Affiliation>Abbott Vascular, Santa Clara, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ozaki</LastName><ForeName>Yukio</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Fujita Health University Hospital, Toyoake, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Whitbourn</LastName><ForeName>Robert</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Cardiovascular Research Center, St. Vincent's Hospital, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bartorelli</LastName><ForeName>Antonio</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Centro Cardiologico Monzino, IRCCS, University of Milan, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stone</LastName><ForeName>Gregg W</ForeName><Initials>GW</Initials><AffiliationInfo><Affiliation>Columbia University Medical Center/New York-Presbyterian Hospital and Cardiovascular Research Foundation, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abizaid</LastName><ForeName>Alexandre</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Instituto Dante Pazzanese de Cardiologia, São Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Serruys</LastName><ForeName>Patrick W</ForeName><Initials>PW</Initials><AffiliationInfo><Affiliation>Thoraxcenter, Erasmus Medical Center, Rotterdam, the Netherlands. Electronic address: p.w.j.c.serruys@erasmusmc.nl.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>ABSORB Cohort B Investigators</CollectiveName></Author><Author ValidYN="Y"><CollectiveName>ABSORB EXTEND Investigators</CollectiveName></Author><Author ValidYN="Y"><CollectiveName>SPIRIT FIRST Investigators</CollectiveName></Author><Author ValidYN="Y"><CollectiveName>SPIRIT II Investigators</CollectiveName></Author><Author ValidYN="Y"><CollectiveName>SPIRIT III Investigators</CollectiveName></Author><Author ValidYN="Y"><CollectiveName>SPIRIT IV Investigators</CollectiveName></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT00180310</AccessionNumber><AccessionNumber>NCT00180453</AccessionNumber><AccessionNumber>NCT00180479</AccessionNumber><AccessionNumber>NCT00307047</AccessionNumber><AccessionNumber>NCT00856856</AccessionNumber><AccessionNumber>NCT01023789</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>04</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JACC Cardiovasc Interv</MedlineTA><NlmUniqueID>101467004</NlmUniqueID><ISSNLinking>1936-8798</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D002317">Cardiovascular Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>9HW64Q8G6G</RegistryNumber><NameOfSubstance UI="D000068338">Everolimus</NameOfSubstance></Chemical><Chemical><RegistryNumber>W36ZG6FT64</RegistryNumber><NameOfSubstance UI="D020123">Sirolimus</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>JACC Cardiovasc Interv. 2014 May;7(5):494-6</RefSource><PMID Version="1">24852803</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D020341" MajorTopicYN="Y">Absorbable Implants</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002317" MajorTopicYN="N">Cardiovascular Agents</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration & dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016009" MajorTopicYN="N">Chi-Square Distribution</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002986" MajorTopicYN="N">Clinical Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D023921" MajorTopicYN="N">Coronary Stenosis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003328" MajorTopicYN="N">Coronary Thrombosis</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003925" MajorTopicYN="N">Diabetic Angiopathies</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000068338" MajorTopicYN="N">Everolimus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053208" MajorTopicYN="N">Kaplan-Meier Estimate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009203" MajorTopicYN="N">Myocardial Infarction</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057216" MajorTopicYN="N">Propensity Score</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011474" MajorTopicYN="N">Prosthesis Design</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020123" MajorTopicYN="N">Sirolimus</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName><QualifierName UI="Q000031" MajorTopicYN="Y">analogs & derivatives</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">bioresorbable scaffold</Keyword><Keyword MajorTopicYN="N">coronary artery disease</Keyword><Keyword MajorTopicYN="N">diabetes mellitus</Keyword><Keyword MajorTopicYN="N">drug-eluting stent</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2013</Year><Month>10</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2013</Year><Month>12</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>01</Month><Day>04</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>4</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>4</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>1</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24746650</ArticleId><ArticleId IdType="pii">S1936-8798(14)00507-X</ArticleId><ArticleId IdType="doi">10.1016/j.jcin.2014.01.155</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>Australie</li><li>Belgique</li><li>Brésil</li><li>France</li><li>Inde</li><li>Italie</li><li>Japon</li><li>Pays-Bas</li><li>États-Unis</li></country><region><li>Californie</li><li>Hollande-Méridionale</li><li>Lombardie</li><li>État de New York</li><li>État de São Paulo</li></region><settlement><li>Milan</li><li>Rotterdam</li><li>São Paulo</li></settlement></list><tree><country name="Japon"><noRegion><name sortKey="Muramatsu, Takashi" sort="Muramatsu, Takashi" uniqKey="Muramatsu T" first="Takashi" last="Muramatsu">Takashi Muramatsu</name></noRegion><name sortKey="Ozaki, Yukio" sort="Ozaki, Yukio" uniqKey="Ozaki Y" first="Yukio" last="Ozaki">Yukio Ozaki</name></country><country name="Pays-Bas"><region name="Hollande-Méridionale"><name sortKey="Onuma, Yoshinobu" sort="Onuma, Yoshinobu" uniqKey="Onuma Y" first="Yoshinobu" last="Onuma">Yoshinobu Onuma</name></region><name sortKey="Diletti, Roberto" sort="Diletti, Roberto" uniqKey="Diletti R" first="Roberto" last="Diletti">Roberto Diletti</name><name sortKey="Garcia Garcia, Hector M" sort="Garcia Garcia, Hector M" uniqKey="Garcia Garcia H" first="Hector M" last="García-García">Hector M. García-García</name><name sortKey="Serruys, Patrick W" sort="Serruys, Patrick W" uniqKey="Serruys P" first="Patrick W" last="Serruys">Patrick W. Serruys</name><name sortKey="Van Geuns, Robert Jan" sort="Van Geuns, Robert Jan" uniqKey="Van Geuns R" first="Robert-Jan" last="Van Geuns">Robert-Jan Van Geuns</name></country><country name="France"><noRegion><name sortKey="Chevalier, Bernard" sort="Chevalier, Bernard" uniqKey="Chevalier B" first="Bernard" last="Chevalier">Bernard Chevalier</name></noRegion></country><country name="Inde"><noRegion><name sortKey="Patel, Tejas M" sort="Patel, Tejas M" uniqKey="Patel T" first="Tejas M" last="Patel">Tejas M. Patel</name></noRegion><name sortKey="Seth, Ashok" sort="Seth, Ashok" uniqKey="Seth A" first="Ashok" last="Seth">Ashok Seth</name></country><country name="Belgique"><noRegion><name sortKey="Dorange, Cecile C" sort="Dorange, Cecile C" uniqKey="Dorange C" first="Cécile C" last="Dorange">Cécile C. Dorange</name></noRegion><name sortKey="Veldhof, Susan" sort="Veldhof, Susan" uniqKey="Veldhof S" first="Susan" last="Veldhof">Susan Veldhof</name></country><country name="États-Unis"><region name="Californie"><name sortKey="Cheong, Wai Fung" sort="Cheong, Wai Fung" uniqKey="Cheong W" first="Wai-Fung" last="Cheong">Wai-Fung Cheong</name></region><name sortKey="Stone, Gregg W" sort="Stone, Gregg W" uniqKey="Stone G" first="Gregg W" last="Stone">Gregg W. Stone</name></country><country name="Australie"><noRegion><name sortKey="Whitbourn, Robert" sort="Whitbourn, Robert" uniqKey="Whitbourn R" first="Robert" last="Whitbourn">Robert Whitbourn</name></noRegion></country><country name="Italie"><region name="Lombardie"><name sortKey="Bartorelli, Antonio" sort="Bartorelli, Antonio" uniqKey="Bartorelli A" first="Antonio" last="Bartorelli">Antonio Bartorelli</name></region></country><country name="Brésil"><region name="État de São Paulo"><name sortKey="Abizaid, Alexandre" sort="Abizaid, Alexandre" uniqKey="Abizaid A" first="Alexandre" last="Abizaid">Alexandre Abizaid</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003877 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 003877 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Asie
|area= AustralieFrV1
|flux= PubMed
|étape= Checkpoint
|type= RBID
|clé= pubmed:24746650
|texte= 1-year clinical outcomes of diabetic patients treated with everolimus-eluting bioresorbable vascular scaffolds: a pooled analysis of the ABSORB and the SPIRIT trials.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:24746650" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \
| NlmPubMed2Wicri -a AustralieFrV1
| This area was generated with Dilib version V0.6.33. |  |